Field & Main Bank’s Idexx Laboratories IDXX Stock Holding History

Field & Main Bank’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.2K	Hold	20	–	–	﹤0.01%	226
2025 Q4	$13.5K	Hold	20	–	–	﹤0.01%	222
2025 Q3	$12.8K	Hold	20	–	–	﹤0.01%	219
2025 Q2	$10.7K	Hold	20	–	–	﹤0.01%	218
2025 Q1	$8.4K	Hold	20	–	–	﹤0.01%	223
2024 Q4	$8.27K	Hold	20	–	–	﹤0.01%	232
2024 Q3	$10.1K	Hold	20	–	–	﹤0.01%	222
2024 Q2	$9.74K	Hold	20	–	–	﹤0.01%	225
2024 Q1	$10.8K	Hold	20	–	–	﹤0.01%	221
2023 Q4	$11.1K	Hold	20	–	–	﹤0.01%	214
2023 Q3	$8.74K	Hold	20	–	–	﹤0.01%	227
2023 Q2	$10K	Hold	20	–	–	0.01%	225
2023 Q1	$10K	Hold	20	–	–	0.01%	223
2022 Q4	$8.16K	Hold	20	–	–	0.01%	237
2022 Q3	$7K	Hold	20	–	–	﹤0.01%	237
2022 Q2	$7K	Hold	20	–	–	﹤0.01%	260
2022 Q1	$11K	Hold	20	–	–	0.01%	202
2021 Q4	$13K	Buy	+20	New	+$12.6K	0.01%	203

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Field & Main Bank's IDXX Position: Q1 2026 in Review

Field & Main Bank held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 20 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #226.

Field & Main Bank first reported a position in IDXX in Q4 2021 and has held it in 18 quarters since. The position peaked at $13.5K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Field & Main Bank held 20 shares of Idexx Laboratories worth $11.2K as of Q1 2026.
Field & Main Bank left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up ﹤0.01% of Field & Main Bank's portfolio in Q1 2026, its #226 holding.
Field & Main Bank first reported a position in Idexx Laboratories in Q4 2021 and has held it in 18 quarters since.
Field & Main Bank's Idexx Laboratories position peaked at $13.5K in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Field & Main Bank's 13F filing for Q1 2026, filed 10 Apr 2026.